Jeil Pharmaceutical Co Ltd (271980) — Financial Flexibility Index
Jeil Pharmaceutical Co Ltd (271980) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of ₩-2.50 Billion (operating CF ₩-9.47 Billion minus capex ₩6.97 Billion) represents 0% of total liabilities (₩272.85 Billion). Check total reinvestment intensity of Jeil Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jeil Pharmaceutical Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Jeil Pharmaceutical Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Jeil Pharmaceutical Co Ltd (271980) cash conversion ratio.
Annual Financial Flexibility Index for Jeil Pharmaceutical Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Jeil Pharmaceutical Co Ltd. Explore Jeil Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | ₩3.39 Billion | ₩-5.69 Billion | ₩259.55 Billion | ▼ -59.3% |
| 2024 | 0.03x | ₩9.83 Billion | ₩3.21 Billion | ₩306.38 Billion | ▲ +130.5% |
| 2023 | 0.01x | ₩4.60 Billion | ₩-4.98 Billion | ₩330.29 Billion | ▲ +131.4% |
| 2022 | 0.01x | ₩1.81 Billion | ₩-15.15 Billion | ₩301.29 Billion | ▼ -93.6% |
| 2021 | 0.09x | ₩24.44 Billion | ₩19.10 Billion | ₩259.14 Billion | ▲ +234.5% |
| 2020 | -0.07x | ₩-16.64 Billion | ₩-19.05 Billion | ₩237.18 Billion | ▼ -154.1% |
| 2019 | 0.13x | ₩30.04 Billion | ₩28.96 Billion | ₩231.54 Billion | ▼ -10.9% |
| 2018 | 0.15x | ₩31.74 Billion | ₩21.45 Billion | ₩217.97 Billion | ▲ +16350.6% |
| 2017 | 0.00x | ₩-211.24 Million | ₩-4.21 Billion | ₩235.74 Billion | — |